PASG - Passage Bio Inc
8.4
0.280 3.333%
Share volume: 66,082
Last Updated: 03-06-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.17%
PREVIOUS CLOSE
CHG
CHG%
$8.12
0.28
0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-14-2024 | 08-08-2024 | 11-13-2024 | 03-04-2025 | 05-13-2025 | 11-10-2025 | 03-03-2026 | |
| Cash flow financing | 8.742 M | 85.000 K | 0.000 | 47.000 K | 0.000 | 0.000 | 9.000 K | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | 15.064 M | -12.003 M | 0.000 | 5.281 M | 25.784 M | 0.000 | 0.000 | |
| Net income | -16.711 M | -15.991 M | -19.340 M | -12.725 M | -15.405 M | -7.749 M | -12.983 M | |
| Depreciation | 806.000 K | 797.000 K | 759.000 K | 719.000 K | 201.000 K | 181.000 K | 177.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 25.251 M | 1.048 M | 14.969 M | 13.678 M | 39.631 M | 0.000 | 0.000 | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 20.000 K | 14.000 K | -585.000 K | 0.000 | 0.000 | |
| Cash Change | 15.064 M | -12.003 M | 7.522 M | 5.281 M | 25.784 M | -4.853 M | -6.470 M |